EE160 Tepotinib for the Treatment of Adult Patients with Metastatic Non-Small Cell Lung Cancer Harboring METEX14 Skipping Alterations: A US Cost-Effectiveness Analysis
作者
M. Yang,R Sachdev,Matthew Stargardter,Jonathan C. Tosh,Helene Vioix
出处
期刊:Value in Health [Elsevier BV] 日期:2022-06-25卷期号:25 (7): S365-S365